Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
6,192.47
5,277.74
4,270.19
3,872.99
2,979.01
2,847.83
2,734.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,192.47
5,277.74
4,270.19
3,872.99
2,979.01
2,847.83
2,734.05
Raw Material Cost
3,706.78
3,466.82
2,835.92
2,465.57
1,906.13
1,870.74
1,742.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
39.92
29.97
22.09
21.84
24.22
17.78
25.73
Selling and Distribution Expenses
1,221.80
992.58
859.90
754.36
574.00
511.95
501.33
Other Expenses
-2.85
-2.11
-1.45
-2.18
-2.42
-1.78
-2.57
Total Expenditure (Excl Depreciation)
4,939.97
4,468.29
3,703.36
3,219.93
2,480.13
2,382.69
2,243.53
Operating Profit (PBDIT) excl Other Income
1252.5
809.4
566.8
653.1
498.9
465.09999999999997
490.5
Other Income
26.64
29.26
12.42
-29.12
23.85
23.05
28.39
Operating Profit (PBDIT)
1,765.55
1,320.92
973.81
967.61
704.12
648.62
677.02
Interest
39.92
29.97
22.09
21.84
24.22
17.78
25.73
Exceptional Items
5.06
0.00
4.06
0.00
-15.32
1.19
18.29
Gross Profit (PBDT)
2,485.69
1,810.91
1,434.28
1,407.42
1,072.88
977.09
991.85
Depreciation
588.66
570.68
464.47
411.84
241.00
220.03
217.95
Profit Before Tax
1,142.02
720.26
491.31
533.93
423.58
412.00
451.65
Tax
308.59
199.28
154.09
153.27
136.64
126.80
138.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
833.43
520.98
337.22
380.66
286.94
285.19
312.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
833.43
520.98
337.22
380.66
286.94
285.19
312.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
833.43
520.98
337.22
380.66
286.94
285.19
312.82
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,881.38
4,148.53
3,811.42
3,706.04
2,509.92
2,336.19
2,133.90
Earnings per share (EPS)
64.49
40.17
24.25
30.64
23.6
23.4
24.85
Diluted Earnings per share
64.49
40.17
24.25
30.64
23.6
23.4
24.85
Operating Profit Margin (Excl OI)
18.57%
13.66%
11.64%
15.1%
14.75%
14.24%
15.75%
Gross Profit Margin
27.95%
24.46%
22.38%
24.42%
22.31%
22.19%
24.49%
PAT Margin
13.46%
9.87%
7.9%
9.83%
9.63%
10.01%
11.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.33% vs 23.59% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 59.96% vs 54.51% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 34.62% vs 34.36% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 33.00% vs 35.75% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Japan Animal Referral Medical Center Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
6,192.47
45,579.00
-39,386.53
-86.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,192.47
45,579.00
-39,386.53
-86.41%
Raw Material Cost
3,706.78
41,534.00
-37,827.22
-91.08%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
39.92
71.00
-31.08
-43.77%
Selling and Distribution Expenses
1,221.80
2,510.00
-1,288.20
-51.32%
Other Expenses
-2.85
0.80
-3.65
-456.25%
Total Expenditure (Excl Depreciation)
4,939.97
44,123.00
-39,183.03
-88.80%
Operating Profit (PBDIT) excl Other Income
1,252.50
1,456.00
-203.50
-13.98%
Other Income
26.64
47.00
-20.36
-43.32%
Operating Profit (PBDIT)
1,765.55
2,014.00
-248.45
-12.34%
Interest
39.92
71.00
-31.08
-43.77%
Exceptional Items
5.06
-625.00
630.06
100.81%
Gross Profit (PBDT)
2,485.69
4,045.00
-1,559.31
-38.55%
Depreciation
588.66
511.00
77.66
15.20%
Profit Before Tax
1,142.02
807.00
335.02
41.51%
Tax
308.59
428.00
-119.41
-27.90%
Provisions and contingencies
0
0
0.00
Profit After Tax
833.43
378.00
455.43
120.48%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
833.43
378.00
455.43
120.48%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
833.43
378.00
455.43
120.48%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,881.38
19,039.00
-14,157.62
-74.36%
Earnings per share (EPS)
64.49
20.87
43.62
209.01%
Diluted Earnings per share
64.49
20.87
43.62
209.01%
Operating Profit Margin (Excl OI)
18.57%
3.19%
0.00
15.38%
Gross Profit Margin
27.95%
2.89%
0.00
25.06%
PAT Margin
13.46%
0.83%
0.00
12.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 619.25 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 17.33% vs 23.59% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 83.34 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 59.96% vs 54.51% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 173.89 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 34.62% vs 34.36% in Mar 2025
Annual - Interest
Interest 3.99 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 33.00% vs 35.75% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.57%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
